Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Torasemide (also known as torsemide and 托拉塞米 in Chinese) is a potent loop diuretic of the pyridine-sulfonylurea class. It is primarily used to treat edema associated with heart failure, kidney disease, and liver cirrhosis. Torasemide can also be used for hypertension but is less preferred for this indication. Its mechanism involves inhibition of sodium and chloride reabsorption in the thick ascending limb of the loop of Henle by blocking the Na+-K+-2Cl− cotransporter. This leads to increased excretion of sodium, chloride, and water in urine. Torasemide also exhibits anti-mineralocorticoid effects by inhibiting aldosterone secretion and action at renal tubular cells. Compared to furosemide (another loop diuretic), it has a longer duration of action and may result in less potassium loss[1][5][7]. It is available as an oral tablet or intravenous injection for humans; veterinary formulations exist for dogs with heart failure[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on torasemide.